Reply to : "comment on 'oral diabetes medications other than dipeptidyl peptidase-4 inhibitors are not associated with bullous pemphigoid: a Finnish nationwide case control study'"
Varpuluoma, Outi; Huilaja, Laura; Tasanen, Kaisa (2018-11-09)
Varpuluoma, Outi
Huilaja, Laura
Tasanen, Kaisa
Elsevier
09.11.2018
Outi Varpuluoma, Laura Huilaja, Kaisa Tasanen, Reply to: “Comment on ‘Oral diabetes medications other than dipeptidyl peptidase-4 inhibitors are not associated with bullous pemphigoid: A Finnish nationwide case control study’”, Journal of the American Academy of Dermatology, Volume 79, Issue 6, 2018, Pages e113-e114, ISSN 0190-9622, https://doi.org/10.1016/j.jaad.2018.06.042
https://creativecommons.org/licenses/by-nc-nd/4.0/
© 2018 by the American Academy of Dermatology, Inc. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/.
https://creativecommons.org/licenses/by-nc-nd/4.0/
© 2018 by the American Academy of Dermatology, Inc. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/.
https://creativecommons.org/licenses/by-nc-nd/4.0/
Julkaisun pysyvä osoite on
https://urn.fi/URN:NBN:fi-fe2019102835041
https://urn.fi/URN:NBN:fi-fe2019102835041
Kokoelmat
- Avoin saatavuus [31657]